Oruka Therapeutics (ORKA) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -111.18% |
| Dec 31, 2025 | -162.47% |
| Sep 30, 2025 | -99.12% |
| Jun 30, 2025 | -91.95% |
| Mar 31, 2025 | -134.71% |
| Dec 31, 2024 | -91.66% |
| Sep 30, 2024 | -90.53% |
| Jun 30, 2024 | 19.24% |
| Mar 31, 2024 | 18.75% |
| Dec 31, 2023 | 8.63% |
| Sep 30, 2023 | 9.01% |
| Jun 30, 2023 | -53.79% |
| Mar 31, 2023 | -82.92% |
| Dec 31, 2022 | -71.85% |
| Sep 30, 2022 | -65.77% |
| Jun 30, 2022 | -67.02% |
| Mar 31, 2022 | -82.99% |
| Dec 31, 2021 | -100.62% |
| Sep 30, 2021 | -93.27% |
| Jun 30, 2021 | -87.19% |
| Mar 31, 2021 | -76.87% |
| Dec 31, 2020 | -61.03% |
| Sep 30, 2020 | -47.41% |
| Jun 30, 2020 | 11.64% |
| Mar 31, 2020 | 29.70% |
| Dec 31, 2019 | 26.62% |
| Sep 30, 2019 | 25.65% |
| Jun 30, 2019 | 27.69% |
| Mar 31, 2019 | 36.06% |
| Dec 31, 2018 | 44.57% |
| Sep 30, 2018 | 42.04% |
| Jun 30, 2018 | 39.76% |
| Mar 31, 2018 | 0.24% |
| Dec 31, 2017 | 8.53% |
| Sep 30, 2017 | 2.57% |
| Jun 30, 2017 | 6.17% |
| Mar 31, 2017 | 3.23% |
| Dec 31, 2016 | -8.09% |
| Sep 30, 2016 | -8.00% |
| Jun 30, 2016 | -8.96% |
| Mar 31, 2016 | -105.35% |
| Dec 31, 2015 | -136.86% |
| Sep 30, 2015 | -137.90% |
| Jun 30, 2015 | -140.18% |
| Mar 31, 2015 | -42.32% |
| Dec 31, 2014 | -37.22% |
| Sep 30, 2014 | -44.24% |
| Jun 30, 2014 | -37.44% |
| Mar 31, 2014 | -60.95% |
| Dec 31, 2013 | -33.61% |
| Sep 30, 2013 | -33.08% |
| Jun 30, 2013 | -27.13% |